Owlstone Medical last week announced that it has forged a partnership with Thermo Fisher Scientific‘s (NYSE:TMO) to advance non-invasive breath sampling in disease detection. Through the agreement, both companies will integrate the Thermo Scientific Q Exactive GC Hybrid Quadrupole-Orbitrap MassSpectrometer into Owlstone Medical’s Breath Biopsy platform. The collaboration will hopefully qualify the mass analyzer for detecting biomarkers […]
Thermo Fisher prices $5.72B in senior notes offerings
Thermo Fisher Scientific (NYSE:TMO) said today that it has priced an aggregate principal offering of €4.4 billion ($4.82 billion USD) of euro-denominated notes and a separate $900 million aggregate principal offering of USD-denominated notes. The euro offering is expected to close on or about September 30, 2019, and the USD offering is expected to close […]
Report: Healthcare CEO pay balloons to $2.6B, quality of care not a factor in bonuses
Healthcare chief execs at 177 top companies collectively saw their compensation grow to $2.6 billion last year while quality of care and improvements to healthcare spending remained at most a marginal factor to their pay, according to an Axios analysis. Despite a focus on pharmaceutical CEOs, medical device company chief execs were five of the […]
Thermo Fisher to buy Irish drug manufacturing site from GSK for $101m
Thermo Fisher Scientific‘s (NYSE:TMO) said today that it inked a deal to acquire a Cork, Ireland-based drug substance manufacturing site from GlaxoSmithKline (NYSE:GSK) for approximately $100.6 million (EU €90 million). Waltham, Mass.-based Thermo Fisher said that the acquisition of the new site will allow it to expand capacity and meet customer demand for both the development and […]
Thermo Fisher to drop $1.7B on gene therapy maker Brammer Bio
Thermo Fisher (NYSE:TMO) said today that it will acquire gene and cell therapy manufacturer Brammer Bio for $1.7 billion in cash. Brammer Bio is a viral vector contract developer and manufacturer of gene therapies and gene-modified cell therapies for biopharma customers. The Cambridge, Mass.-based business has nearly 600 employees at primary locations in Massachusetts and Alachua, Fla. Get […]
Ex-NuVasive CEO Lucier to head new M&A firm Corza Health
Recently departed NuVasive (NSDQ:NUVA) CEO Gregory Lucier will lead a new company formed to acquire medtech and life sciences firms and assets. Lucier, 54, is partnering with Chicago-based private equity firm GTCR to form the new company, Corza Health, in San Diego. GTCR holds stakes in Regatta Medical, which owns laser micro manufacturer Resonetics and Sotera Health along with life sciences, technology, and […]
Owens & Minor taps former Thermo Fisher CCO Pesicka as prez, CEO | Personnel Moves – February 27, 2019
Owens & Minor (NYSE:OMI) said this month that it named former Thermo Fisher Scientific chief commercial officer Edward Pesicka as its new prez & CEO, effective March 4. Pesicka will replace interim prez & CEO Robert Sledd, who will continue to serve as board chair, the Richmond, Va.-based company said. Prior to his position as chief […]
BD deals bioprocessing biz to Thermo Fisher
Thermo Fisher (NYSE:TMO) said yesterday it inked a deal to pick up Becton Dickinson‘s (NYSE:BDX) Advanced Bioprocessing business for an undisclosed amount. The divested assets include a technical services program with a variety of peptones intended to enhance cell culture media formulations to improve yield and reduce variability in biopharmaceutical applications, Thermo Fisher said. The Advanced Bioprocessing […]
FDA approves diagnostic that simultaneously screens for multiple lung cancer types
The FDA said today that it awarded premarket approval to Thermo Fisher Scientific’s (NYSE:TMO) next-gen sequencing-based test that can simultaneously screen tumor samples for biomarkers associated with 3 approved therapies for non-small cell lung cancer. The company’s Oncomine Dx Target Test evaluates 23 genes associated with non-small cell lung cancer. The tests results could help […]
Thermo Fisher closes $4B buyout of electron microscopy firm FEI
Thermo Fisher (NYSE:TMO) said today that it closed the $4.2 billion acquisition of electron microscopy company FEI Co. for $107.5 per share in cash. FEI designs, manufactures and supports high-performance electron microscopy workflows, Thermo Fisher said. The company has more than 3,000 employees worldwide and reported revenues of $930 million last year. “We are pleased to complete this […]
Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016
Schellhorn out, Emerson in as Monteris CEO Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year. Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year […]
- 1
- 2
- 3
- …
- 7
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube